Medicare Enrolled
Dr. Robin Schaffran, M.D.
Procedural Dermatology Physician · Beverly Hills, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Schaffran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schaffran?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Schaffran
Dr. Robin Schaffran is a procedural dermatology physician in Beverly Hills, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Schaffran performed 9,782 Medicare services across 4,622 unique beneficiaries.
Between the years covered by Open Payments, Dr. Schaffran received a total of $10,384 from 49 pharmaceutical and/or device companies across 523 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in procedural dermatology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Schaffran is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 19% volume in CA
$10,384 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,782
Medicare services
Top 19% in CA for procedural dermatology physician
4,622
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~489 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
3,371 | $6 | $13 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,854 | $71 | $111 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
1,293 | $31 | $52 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
1,049 | $82 | $131 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
848 | $38 | $95 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
252 | $77 | $140 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
229 | $1 | $6 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
158 | $92 | $138 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
114 | $107 | $150 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
101 | $37 | $72 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
99 | $46 | $76 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
82 | $112 | $296 |
| Complex or multiple skin abscess drainage A procedure to drain one or more skin abscesses that are complex in nature. This involves opening and cleaning the infected pockets under the skin. |
60 | $182 | $251 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
58 | $385 | $515 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
40 | $44 | $70 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
34 | $364 | $490 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
31 | $414 | $592 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
31 | $10 | $31 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
23 | $108 | $313 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
21 | $142 | $200 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
19 | $134 | $325 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
15 | $68 | $127 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,384
Total received (2018-2024)
Avg $1,483/year across 7 years
Top 21% in CA for procedural dermatology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
523
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,384 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,748
2023
$1,831
2022
$1,462
2021
$1,337
2020
$830
2019
$1,731
2018
$1,444
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$355
ABBVIE INC.
$266
Regeneron Healthcare Solutions, Inc.
$254
Janssen Biotech, Inc.
$199
Incyte Corporation
$94
Lilly USA, LLC
$88
PFIZER INC.
$81
Galderma Laboratories, L.P.
$65
Dermavant Sciences, Inc.
$57
UCB, Inc.
$52
LEO Pharma Inc.
$45
Arcutis Biotherapeutics, Inc.
$38
Ortho Dermatologics, a division of Bausch Health US, LLC
$36
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
E.R. Squibb & Sons, L.L.C.
$21
SUN PHARMACEUTICAL INDUSTRIES INC.
$20
MAYNE PHARMA COMMERCIAL LLC
$19
Amgen Inc.
$17
Journey Medical Corporation
$17
Top 3 companies account for 50.1% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$1,198
Janssen Biotech, Inc.
$927
Regeneron Healthcare Solutions, Inc.
$916
Galderma Laboratories, L.P.
$564
Amgen Inc.
$515
Lilly USA, LLC
$489
LEO Pharma Inc.
$484
Sun Pharmaceutical Industries Inc.
$408
Ortho Dermatologics, a division of Bausch Health US, LLC
$380
ABBVIE INC.
$374
Novartis Pharmaceuticals Corporation
$350
AbbVie Inc.
$346
Mayne Pharma Inc.
$294
Celgene Corporation
$254
PFIZER INC.
$241
Almirall LLC
$239
SUN PHARMACEUTICAL INDUSTRIES INC.
$219
Incyte Corporation
$185
AbbVie, Inc.
$168
EPI Health, LLC
$143
Allergan Inc.
$140
Dermavant Sciences, Inc.
$139
Glenmark Therapeutics Inc.
$132
UCB, Inc.
$125
E.R. Squibb & Sons, L.L.C.
$117
VYNE Pharmaceuticals Inc.
$110
Arcutis Biotherapeutics, Inc.
$104
MAYNE PHARMA INC.
$94
Exeltis, USA Inc.
$76
SANOFI-AVENTIS U.S. LLC
$75
Journey Medical Corporation
$74
Allergan, Inc.
$52
Mission Pharmacal Company
$44
Bayer HealthCare Pharmaceuticals Inc.
$44
Nabriva Therapeutics, plc
$38
MAYNE PHARMA COMMERCIAL LLC
$38
Merz North America, Inc.
$36
Encore Dermatology Inc.
$33
Krystal Biotech Inc
$29
Medimetriks Pharmaceuticals, Inc.
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Helsinn Therapeutics (U.S.), Inc.
$20
Genentech USA, Inc.
$19
Promius Pharma LLC
$19
DERMIRA, INC.
$19
Sandoz Inc.
$17
Pierre Fabre Pharmaceuticals, Inc.
$15
PruGen, Inc. Pharmaceuticals
$15
Mylan Pharmaceuticals Inc.
$14
Top 3 companies account for 29.3% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMZEEQ · ARAZLO · Absorica LD · Aczone · Avar · BIAFINE · BOTOX · BOTOX COSMETIC · BRYHALI · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Cimzia · Cloderm Cream · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIDEL · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Ecoza · Enbrel · Exelderm · FINACEA · Finacea · Genadur · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · Klisyri · LIBTAYO · Mupirocin Cream · Neo-Synalar Cream Kit · ONEXTON · OPZELURA · ORACEA · Odomzo · Olux · Otezla · PICATO · QBREXZA · REMICADE · RETIN-A-MICRO · RINVOQ · SKYRIZI · SPEVIGO · Seysara · Sitavig · Sivextro · Skyrizi · Sotyktu · TALTZ · TREMFYA · TargaDox · Tremfya · VALCHLOR · VTAMA · VYJUVEK · Veltin · Winlevi · Xolair · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Procedural dermatology physicians within 10 mi
29
Per 100K population
0.3
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.8 mi
0.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Schaffran is a clinical cardiology specialist, with above-average Medicare volume (top 19% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Schaffran experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Schaffran performed 3,371 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schaffran receive payments from pharmaceutical companies?
Yes. Dr. Schaffran received a total of $10,384 from 49 companies across 523 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schaffran's costs compare to other procedural dermatology physicians in Beverly Hills?
Dr. Schaffran's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schaffran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Procedural Dermatology Physicians in Beverly Hills
Browse procedural dermatology physicians in Beverly Hills ranked by procedure volume and transparency data.
Highest volume
Top Procedural Dermatology Physicians in CA
Procedural dermatology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Procedural Dermatology Physicians in CA
Which CA procedural dermatology physicians receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology